de First Manhattan ProShares Ultra Health Care RXL Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 480 k | Mantener |
9,044
| – | – | ﹤0.01% | 575 |
|
|
2026
Q1 | USD 415 k | Mantener |
9,044
| – | – | ﹤0.01% | 601 |
|
|
2025
Q4 | USD 469 k | Mantener |
9,044
| – | – | ﹤0.01% | 569 |
|
|
2025
Q3 | USD 385 k | Mantener |
9,044
| – | – | ﹤0.01% | 587 |
|
|
2025
Q2 | USD 369 k | Vender |
9,044
-1,600
| -15% | -USD 65.8 k | ﹤0.01% | 586 |
|
|
2025
Q1 | USD 518 k | Mantener |
10,644
| – | – | ﹤0.01% | 490 |
|
|
2024
Q4 | USD 468 k | Mantener |
10,644
| – | – | ﹤0.01% | 513 |
|
|
2024
Q3 | USD 597 k | Vender |
10,644
-800
| -7% | -USD 43.6 k | ﹤0.01% | 452 |
|
|
2024
Q2 | USD 585 k | Vender |
11,444
-1,856
| -14% | -USD 91.9 k | ﹤0.01% | 442 |
|
|
2024
Q1 | USD 707 k | Vender |
13,300
-950
| -7% | -USD 47.7 k | ﹤0.01% | 427 |
|
|
2023
Q4 | USD 651 k | Vender |
14,250
-14,400
| -50% | -USD 602 k | ﹤0.01% | 431 |
|
|
2023
Q3 | USD 1.18 M | Vender |
28,650
-1,200
| -4% | -USD 52.9 k | ﹤0.01% | 363 |
|
|
2023
Q2 | USD 1.33 M | Mantener |
29,850
| – | – | ﹤0.01% | 359 |
|
|
2023
Q1 | USD 1.28 M | Mantener |
29,850
| – | – | ﹤0.01% | 379 |
|
|
2022
Q4 | USD 1.41 M | Vender |
29,850
-2,600
| -8% | -USD 118 k | 0.01% | 377 |
|
|
2022
Q3 | USD 1.25 M | Vender |
32,450
-500
| -2% | -USD 22 k | 0.01% | 383 |
|
|
2022
Q2 | USD 1.44 M | Vender |
32,950
-3,600
| -10% | -USD 165 k | 0.01% | 372 |
|
|
2022
Q1 | USD 1.87 M | Vender |
36,550
-1,200
| -3% | -USD 57.8 k | 0.01% | 373 |
|
|
2021
Q4 | USD 2.11 M | Vender |
37,750
-250
| -0.7% | -USD 12.7 k | 0.01% | 339 |
|
|
2021
Q3 | USD 1.8 M | Mantener |
38,000
| – | – | 0.01% | 350 |
|
|
2021
Q2 | USD 1.77 M | Vender |
38,000
-300
| -0.8% | -USD 13.1 k | 0.01% | 344 |
|
|
2021
Q1 | USD 1.53 M | Vender |
38,300
-100
| -0.3% | -USD 3.95 k | 0.01% | 362 |
|
|
2020
Q4 | USD 1.45 M | Mantener |
38,400
| – | – | 0.01% | 351 |
|
|
2020
Q3 | USD 1.25 M | Vender |
38,400
-400
| -1% | -USD 12.9 k | 0.01% | 362 |
|
|
2020
Q2 | USD 1.14 M | Mantener |
38,800
| – | – | 0.01% | 371 |
|
|
2020
Q1 | USD 879 k | Vender |
38,800
-400
| -1% | -USD 11.5 k | 0.01% | 392 |
|
|
2019
Q4 | USD 1.25 M | Mantener |
39,200
| – | – | 0.01% | 386 |
|
|
2019
Q3 | USD 962 k | Vender |
39,200
-1,200
| -3% | -USD 30.5 k | 0.01% | 418 |
|
|
2019
Q2 | USD 1.06 M | Vender |
40,400
-800
| -2% | -USD 19.8 k | 0.01% | 422 |
|
|
2019
Q1 | USD 1.08 M | Vender |
41,200
-600
| -1% | -USD 15.1 k | 0.01% | 426 |
|
|
2018
Q4 | USD 950 k | Mantener |
41,800
| – | – | 0.01% | 446 |
|
|
2018
Q3 | USD 1.21 M | Vender |
41,800
-800
| -2% | -USD 21 k | 0.01% | 439 |
|
|
2018
Q2 | USD 962 k | Vender |
42,600
-1,200
| -3% | -USD 26.4 k | 0.01% | 449 |
|
|
2018
Q1 | USD 938 k | Vender |
43,800
-800
| -2% | -USD 18.6 k | 0.01% | 441 |
|
|
2017
Q4 | USD 983 k | Mantener |
44,600
| – | – | 0.01% | 450 |
|
|
2017
Q3 | USD 953 k | Mantener |
44,600
| – | – | 0.01% | 450 |
|
|
2017
Q2 | USD 892 k | Vender |
44,600
-800
| -2% | -USD 14.7 k | 0.01% | 450 |
|
|
2017
Q1 | USD 796 k | Vender |
45,400
-4,200
| -8% | -USD 70.7 k | ﹤0.01% | 458 |
|
|
2016
Q4 | USD 745 k | Vender |
49,600
-800
| -2% | -USD 12.1 k | ﹤0.01% | 452 |
|
|
2016
Q3 | USD 829 k | Vender |
50,400
-2,400
| -5% | -USD 40.5 k | 0.01% | 445 |
|
|
2016
Q2 | USD 844 k | Mantener |
52,800
| – | – | 0.01% | 439 |
|
|
2016
Q1 | USD 755 k | Mantener |
52,800
| – | – | ﹤0.01% | 446 |
|
|
2015
Q4 | USD 870 k | Mantener |
52,800
| – | – | 0.01% | 437 |
|
|
2015
Q3 | USD 752 k | Mantener |
52,800
| – | – | ﹤0.01% | 458 |
|
|
2015
Q2 | USD 982 k | Vender |
52,800
-2,200
| -4% | -USD 40.1 k | 0.01% | 432 |
|
|
2015
Q1 | USD 972 k | Vender |
55,000
-4,000
| -7% | -USD 67.4 k | 0.01% | 432 |
|
|
2014
Q4 | USD 913 k | Vender |
59,000
-5,200
| -8% | -USD 76.6 k | 0.01% | 438 |
|
|
2014
Q3 | USD 864 k | Vender |
64,200
-1,600
| -2% | -USD 20.7 k | 0.01% | 446 |
|
|
2014
Q2 | USD 806 k | Mantener |
65,800
| – | – | 0.01% | 445 |
|
|
2014
Q1 | USD 741 k | Mantener |
65,800
| – | – | ﹤0.01% | 456 |
|
|
2013
Q4 | USD 667 k | Vender |
65,800
-3,800
| -5% | -USD 35.9 k | ﹤0.01% | 476 |
|
|
2013
Q3 | USD 597 k | Mantener |
69,600
| – | – | ﹤0.01% | 474 |
|
|
2013
Q2 | USD 603 k | Comprar |
+69,600
| Nuevas | +USD 528 k | ﹤0.01% | 475 |
|
Otros fondos que tienen RXL en su cartera
Posición de First Manhattan en RXL: resumen de T2 2026
First Manhattan mantuvo sin cambios su posición en ProShares Ultra Health Care (RXL) en T2 2026, con 9,044 acciones por un valor de USD 480 k. La posición representa ﹤0.01% de la cartera y ocupa el puesto #575.
First Manhattan reportó por primera vez una posición en RXL en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 2.11 M en T4 2021. Al cierre de T2 2026, 16 fondos que sigue Wall St. Rank mantienen una posición en RXL.
- Al cierre de T2 2026, First Manhattan tenía 9,044 acciones de ProShares Ultra Health Care con un valor de USD 480 k.
- First Manhattan mantuvo sin cambios su número de acciones de ProShares Ultra Health Care en T2 2026.
- ProShares Ultra Health Care representó ﹤0.01% de la cartera de First Manhattan en T2 2026 y fue su posición número 575.
- First Manhattan reportó por primera vez una posición en ProShares Ultra Health Care en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de First Manhattan en ProShares Ultra Health Care alcanzó su máximo de USD 2.11 M en T4 2021.
- Al cierre de T2 2026, 16 fondos que sigue Wall St. Rank tenían ProShares Ultra Health Care en cartera.
Según el Informe 13F de First Manhattan correspondiente a T2 2026, presentado el 14 ago 2026.